Article thumbnail

Bariatric surgery: an IDF statement for obese Type 2 diabetes

By J B Dixon, P Zimmet, K G Alberti and F Rubino


The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost-effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m2 or more

Topics: Article: Clinical Practice
Publisher: Blackwell Publishing Ltd
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). 000 adults: collaborative analyses of 57 prospective studies. Lancet
  2. (2008). A study on the economic impact of bariatric surgery.
  3. (2004). Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
  4. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
  5. (2004). Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet
  6. (2004). Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics
  7. (2011). Bariatric surgery to treat severely obese patientswith type 2 diabetes: a consensus statement. Obes Res Clin Pract
  8. (2010). Bariatric surgery: a dilemma for the health system?
  9. (2004). Bariatric surgery: a systematic review and metaanalysis.
  10. (2010). Body mass index and mortality among 1.46 million white adults.
  11. (1995). Changes in energy expenditure resulting from altered body weight.
  12. (2008). Colarusso A et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
  13. (2010). Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care
  14. (2009). Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care
  15. (2010). Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep
  16. Diabetes, obesity, and the brain.
  17. (2011). DIABETICMedicine Original article ª 2011 The Authors. Diabetic Medicine ª
  18. (2005). Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.
  19. (2010). Early changes in incretin secretion after laparoscopic duodenal–jejunal bypass surgery in type 2 diabetic patients. Obes Surg
  20. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes. Horm Metab Res
  21. (2004). Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg
  22. (2003). Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg
  23. (2009). Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol
  24. (2007). Effects of bariatric surgery on mortality in Swedish obese subjects.
  25. (2010). Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care
  26. (2001). Etiology of type II diabetes mellitus: role of the foregut.
  27. (2002). Evaluation of risk factors for development of complications
  28. (1994). fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care
  29. (2007). Genetic factors in human obesity. Obes Rev
  30. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract
  31. (2006). guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. London: National Institute for Health and Clinical Excellence,
  32. (2002). Health outcomes of severely obese Type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care
  33. (2009). High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER Study. Clin Cancer Res
  34. (2009). Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther
  35. (2007). Inter-disciplinary European guidelines on surgery of severe obesity.
  36. Lifestyle, diabetes, and cardiovascular risk factors
  37. (2010). Lifetime cost of type 2 diabetes in the US. Presented at the American Diabetes Association meeting,
  38. (2007). Long-term mortality after gastric bypass surgery.
  39. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2005; CD004095. DIABETICMedicine IDF position statement-bariatric surgery
  40. (2008). Longterm follow-up after tight control of blood pressure in type 2 diabetes.
  41. Management of obesity: summary of SIGN guideline.
  42. (2006). Mechanisms linking obesity with cardiovascular disease.
  43. (2009). Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care
  44. (2010). Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol
  45. (2009). Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med
  46. (2009). Obes Surg
  47. (2007). Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis
  48. (1992). of Health. Gastrointestinal surgery for severe obesity:
  49. (1995). Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group, study 16. Diabetes
  50. (2009). Perioperative safety in the longitudinal assessment of bariatric surgery.
  51. (2005). Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev
  52. (2003). Practice Guidelines for the Management of Overweight and Obesity
  53. (2004). Prev Med
  54. preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser
  55. (2001). Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments.
  56. (2001). Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res
  57. (2009). Recent improvements in bariatric surgery outcomes. Med Care
  58. Recommendations for bariatric surgery in adolescents in Australia and New Zealand.
  59. (2007). Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care
  60. (2009). Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg
  61. Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: 9–10
  62. Standards of medical care in diabetes—2010. Diabetes Care
  63. (2007). Substantial intentional weight loss and mortality in the severely obese. Ann Surg
  64. (2009). Surgery for non-obese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. Obes Surg
  65. (2009). Surgery for obesity. Cochrane Database Syst Rev
  66. (2009). The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess
  67. (2010). The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg
  68. (2010). The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract
  69. (2006). The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg
  70. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States:
  71. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI < 35: an analysis of 454 consecutive patients.
  72. (2007). Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery
  73. (2009). Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis
  74. (2007). Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers.
  75. (2009). Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.
  76. Weight gain as a risk factor for clinical diabetes mellitus in women.
  77. (2005). Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.
  78. (1995). Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg